Original drug Polyoxidonium (azoximer bromide) including To the updated temporary guidelines of the Ministry of Health of Russia for the prevention, diagnosis and treatment of the new coronavirus infection.
According to the document, azoxymer bromide is listed under non-specific drug prevention of Covid-19.
The Russian drug was added to the document based on the meta-analysis “Experience with the use of azoximer bromide for the prevention of acute respiratory infections and Covid-19 in adults from groups at high risk of infection (healthcare workers in the red zone).” ” included 1,141 participants ages 18 to 69.
Doctors in the “red zone”, who took the drug as prophylaxis, showed higher resistance to acute respiratory diseases and were diagnosed with Covid-19 3 times less often than the control group.
INSIDE research A favorable tolerability profile of the drug was also noted.
Let us remind you that in the fall of 2023, federal operational center A significant increase in the incidence of coronavirus infection has been recorded. The incidence of new coronavirus infection increased by 30.1% compared to the previous week.